Terms: = Prostate cancer AND ETV4, PEA3, 2118, ENSG00000175832, E1AF, E1A-F, PEAS3 AND Treatment
9 results:
1. Oncogenic ETS Factors in prostate cancer.
Nicholas TR; Strittmatter BG; Hollenhorst PC
Adv Exp Med Biol; 2019; 1210():409-436. PubMed ID: 31900919
[TBL] [Abstract] [Full Text] [Related]
2. Steroid receptor coactivator-1 regulates glioma angiogenesis through polyomavirus enhancer activator 3 signaling.
Zhang Y; Shi W
Biochem Cell Biol; 2019 Aug; 97(4):488-496. PubMed ID: 30532986
[TBL] [Abstract] [Full Text] [Related]
3. ETS (E26 transformation-specific) up-regulation of the transcriptional co-activator TAZ promotes cell migration and metastasis in prostate cancer.
Liu CY; Yu T; Huang Y; Cui L; Hong W
J Biol Chem; 2017 Jun; 292(22):9420-9430. PubMed ID: 28408625
[TBL] [Abstract] [Full Text] [Related]
4. Suppression of CHK1 by ETS Family Members Promotes DNA Damage Response Bypass and Tumorigenesis.
Lunardi A; Varmeh S; Chen M; Taulli R; Guarnerio J; Ala U; Seitzer N; Ishikawa T; Carver BS; Hobbs RM; Quarantotti V; Ng C; Berger AH; Nardella C; Poliseno L; Montironi R; Castillo-Martin M; Cordon-Cardo C; Signoretti S; Pandolfi PP
Cancer Discov; 2015 May; 5(5):550-63. PubMed ID: 25653093
[TBL] [Abstract] [Full Text] [Related]
5. Transcriptional regulatory networks in human lung adenocarcinoma.
Meng X; Lu P; Bai H; Xiao P; Fan Q
Mol Med Rep; 2012 Nov; 6(5):961-6. PubMed ID: 22895549
[TBL] [Abstract] [Full Text] [Related]
6. e1af expression is associated with extra-prostatic growth and matrix metalloproteinase-7 expression in prostate cancer.
Maruta S; Sakai H; Kanda S; Hayashi T; Kanetake H; Miyata Y
APMIS; 2009 Nov; 117(11):791-6. PubMed ID: 19845529
[TBL] [Abstract] [Full Text] [Related]
7. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer.
Tomlins SA; Laxman B; Dhanasekaran SM; Helgeson BE; Cao X; Morris DS; Menon A; Jing X; Cao Q; Han B; Yu J; Wang L; Montie JE; Rubin MA; Pienta KJ; Roulston D; Shah RB; Varambally S; Mehra R; Chinnaiyan AM
Nature; 2007 Aug; 448(7153):595-9. PubMed ID: 17671502
[TBL] [Abstract] [Full Text] [Related]
8. Improving the outcome of patients with castration-resistant prostate cancer through rational drug development.
Attard G; Sarker D; Reid A; Molife R; Parker C; de Bono JS
Br J Cancer; 2006 Oct; 95(7):767-74. PubMed ID: 16983403
[TBL] [Abstract] [Full Text] [Related]
9. Epidural cord compression in association with genitourinary neoplasms.
Liskow A; Chang CH; DeSanctis P; Benson M; Fetell M; Housepian E
Cancer; 1986 Aug; 58(4):949-54. PubMed ID: 3719559
[TBL] [Abstract] [Full Text] [Related]
